Compare FMS & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMS | QXO |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | Germany | United States |
| Employees | 108165 | 7794 |
| Industry | Misc Health and Biotechnology Services | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.6B |
| IPO Year | N/A | N/A |
| Metric | FMS | QXO |
|---|---|---|
| Price | $24.04 | $14.98 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | $30.00 | ★ $32.85 |
| AVG Volume (30 Days) | 579.5K | ★ 26.7M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $70.27 |
| Revenue Next Year | $3.83 | $38.75 |
| P/E Ratio | $15.62 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.02 | $13.82 |
| 52 Week High | $27.64 | $27.61 |
| Indicator | FMS | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 64.14 | 37.52 |
| Support Level | $22.47 | N/A |
| Resistance Level | $24.71 | $18.28 |
| Average True Range (ATR) | 0.29 | 1.01 |
| MACD | 0.06 | -0.21 |
| Stochastic Oscillator | 93.10 | 18.83 |
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.